Adaptimmune Therapeutics Plcの機関の所有権

Adaptimmune Therapeutics Plcの機関の所有権は何ですか。

Adaptimmune Therapeutics Plcの機関の所有権は70.53%です。

機関の所有権の定義は何ですか。



機関所有権は、ミューチュアル・ファンドまたは年金基金、保険会社、投資会社、その他の資金を管理する他の団体が所有する会社の株式数です。

Given the considerable sums of money that institutions invest, it is not surprising that they tend to be much more knowledgeable than the average investor when it comes to the companies and industries in which they have invested.

Institutional portfolio managers often meet personally with a company's top executives, and in many cases the research they conduct is further supported by equity analysts who evaluate prospective companies and industries in great depth before making specific investment recommendations.

NASDAQのセクタHealth Careにおける機関の所有権の企業と比べるAdaptimmune Therapeutics Plc

Adaptimmune Therapeutics Plcは何をしますか。

adaptimmune llc is a multinational, clinical-stage biopharmaceutical company focused on developing novel immunotherapies using its proprietary t-cell receptor platform that has the potential to transform the treatment of cancer. established in 2008, the company has grown from being privately held to one of the most successful biopharmaceutical initial public offerings (ipo) in 2015. with u.s. operations based in philadelphia, pa, adaptimmune is a company founded on strong science that has led to a robust pipeline of immuno-oncology product candidates, a growing research & development platform and ongoing plans for expansion. for more information about adaptimmune, please visit www.adaptimmune.com. if interested in joining our fast growing team, click on the careers tab of this page.

Adaptimmune Therapeutics Plcと類似の機関の所有権